Navidea Biopharmaceuticals Posts Lymphoseek® NDA Update To Company Website

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents, today posted on its website an update to the status of the Lymphoseek NDA review. The web access to the statement can be found on the Navidea Investor page at: http://phx.corporate-ir.net/phoenix.zhtml?c=68527&p=irol-nda.

Copyright Business Wire 2010

If you liked this article you might like

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Insider Trading Alert - EAT, NAVB And INTC Traded By Insiders

Insider Trading Alert - EAT, NAVB And INTC Traded By Insiders

Navidea Biopharmaceuticals (NAVB) Is Strong On High Volume Today

Navidea Biopharmaceuticals (NAVB) Is Strong On High Volume Today

Insider Trading Alert - NAVB, FTNT And OFG Traded By Insiders

Insider Trading Alert - NAVB, FTNT And OFG Traded By Insiders

Insider Trading Alert - NAVB, STFC And CHE Traded By Insiders

Insider Trading Alert - NAVB, STFC And CHE Traded By Insiders